Ashley Hall - Sep 18, 2024 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role: Chief Development Officer
Signature: /s/ Jun Yoon, Attorney-in-Fact
Stock symbol: GPCR
Transactions as of: Sep 18, 2024
Transactions value $: $0
Form type: 4
Date filed: 9/20/2024, 05:47 PM
Previous filing: Aug 29, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GPCR	Ordinary Shares	Award	$0	+67.3K		$0.00	67.3K	Sep 18, 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GPCR	Share option (right to buy)	Award	$0	+82.9K		$0.00	82.9K	Sep 18, 2024	Ordinary Shares	82.9K	$12.75	Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2	Represents restricted stock unit award granted under the Issuer's 2023 Equity Incentive Plan.
F3	The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
F4	One-fourth of the shares vest on the first anniversary of September 18, 2024, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter.